We set out to examine the real-world effects of the Staybalanced supplement on key metabolic markers. Specifically, we analyzed data from 32 patients to see how this unique whole-leaf stevia formulation influences A1C and Fasting Glucose levels over the course of treatment.

The results were statistically significant. We observed a mean reduction of 0.76% in A1C levels across the group.

To put that in perspective, nearly half of the participants (48.4%) achieved a clinically significant improvement of 0.5% or more. In the medical community, shifts of this magnitude are considered very meaningful for long-term health.

The impact on fasting glucose was even more pronounced. The analysis showed a mean decrease of 34.3 mg/dL, which represents a 22.6% reduction from baseline levels.

We saw that the majority of patients—over 95%—showed some level of improvement. This suggests that the supplement is highly effective at supporting the body's ability to manage glucose variability.

Yes, that was one of the most compelling findings. When we looked at the classification of patients, we saw a substantial shift.

For example, in the glucose dataset, the number of participants classified in the "Diabetic" range (≥126 mg/dL) dropped from roughly 59% before treatment to just 9% after treatment. While this is a pilot study, such a dramatic shift indicates a strong therapeutic potential.

The statistical analysis, confirmed by a large "Effect Size" (Cohen’s d), indicates that Staybalanced is an effective intervention for improving glycemic control. It appears to be a valuable natural addition to existing blood sugar management strategies.